Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Coddle Creek Capital, LLC is a venture capital firm founded in 2018 and based in Kannapolis, North Carolina. The firm focuses on providing capital and strategic support to businesses in the life sciences sector, particularly in underserved markets such as North Carolina and New Mexico. Coddle Creek Capital aims to generate investment returns while simultaneously building a robust biotech infrastructure in these regions.
As of now, Coddle Creek Capital operates with a focus on early-stage investments, particularly in pre-seed and seed rounds. The firm is committed to supporting companies through various phases of growth, emphasizing the commercialization of academic intellectual property. Coddle Creek Capital is a registered member of the North Carolina Biotechnology Center directory and is located at the NC Research Campus, a hub for nutrition and genomics research.
Coddle Creek Capital invests primarily in the life sciences sector, targeting areas such as biotech, genomics, healthcare, nutrition, immunology, oncology, microbiome, and neurology. The firm focuses on early-stage investments, particularly pre-seed and seed rounds, with a strong emphasis on commercializing academic intellectual property. Coddle Creek Capital seeks to support companies through different phases of growth, providing not only capital but also strategic support in corporate formation, commercial management, and follow-on capital raising.
The firm operates with a regional focus, primarily in North Carolina and New Mexico, aiming to enhance the growth of businesses in these underserved markets. Coddle Creek Capital's investment strategy is designed to build durable biotech infrastructure while generating returns for its investors. The firm values partnerships with founders who are committed to innovation and growth in the life sciences field.
Coddle Creek Capital's notable portfolio company is Eremid Genomic Services. Eremid focuses on genomics at the intersection of human health, agriculture, plant-based nutrition, and longevity. Following its initial investment, Coddle Creek Capital made an additional investment of $3.0 million in June 2023 after Eremid's acquisition in 2022, signaling strong confidence in the company's potential.
Currently, Eremid remains the sole confirmed investment in Coddle Creek Capital's portfolio. The firm’s strategy emphasizes the importance of supporting companies that are commercializing academic intellectual property, particularly in the life sciences sector.
To pitch Coddle Creek Capital, founders should visit their website at coddlecapital.com. It is recommended to include a comprehensive business plan, details about the team, and insights into the market opportunity. The firm values clear communication and a well-structured pitch deck.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
In June 2023, Coddle Creek Capital made a significant follow-on investment of $3.0 million in Eremid Genomic Services, following the company's acquisition in 2022. This investment reflects the firm's confidence in Eremid's potential within the genomics sector.
Coddle Creek Capital continues to be active in the North Carolina biotechnology community, leveraging its connections at the NC Research Campus to support its portfolio companies.
What stages does Coddle Creek Capital invest in?
Coddle Creek Capital invests in pre-seed, seed, and Series A stages, focusing on early-stage companies in the life sciences sector.
What sectors does Coddle Creek Capital focus on?
The firm primarily invests in biotech, genomics, healthcare, nutrition, immunology, oncology, microbiome, and neurology.
How can startups pitch to Coddle Creek Capital?
Startups can pitch to Coddle Creek Capital by visiting their website at coddlecapital.com. It is advisable to include a detailed business plan and information on the team and market opportunity.
What makes Coddle Creek Capital different from other investors?
Coddle Creek Capital emphasizes building durable biotech infrastructure in underserved markets while providing strategic support alongside capital. This includes assistance with corporate formation and follow-on capital raising.
What is the firm's approach to post-investment involvement?
Coddle Creek Capital actively supports its portfolio companies through strategic guidance, management team recruitment, and partnership facilitation, enhancing their growth potential.
What is the typical check size for investments?
While specific check sizes are not publicly disclosed, Coddle Creek Capital has made significant investments, such as the $3.0 million follow-on investment in Eremid Genomic Services.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.